Cyprus Mail
Cyprus Health

Patients’ rights group slams HIO over decision to limit new-generation drugs

The decision by the Health Insurance Organisation (HIO) to apply limited access to new-generation drugs for cardiovascular disease was condemned on Wednesday by the Cyprus Patients’ Association.

HIO recently decided to limit access to the new drugs under the health scheme Gesy for cardiovascular diseases without consulting scientists in the field, according to the association.

The association said it “supports all the logical actions concerning Gesy but will also protect patients’ rights from any bad decisions no matter who is taking them, and will fight for the right of the patients to receive the medication they need.”

It also said its representatives met with the HIO and asked them to inform doctors and patients before implementing such decisions.

Related Posts

Coronavirus: Court rejects challenge to jab requirement

Nick Theodoulou

Coronavirus: 1690 reinfections in 10 days

Gina Agapiou

Teens arrested for suspected bike theft

Jonathan Shkurko

Snow and rain as Elpis weather system affects Cyprus

Nick Theodoulou

Nicosia hopes UNSG to appoint envoy to facilitate resumption of peace process

Coronavirus: Ministry proud of ‘ground-breaking’ test to stay (updated)

Gina Agapiou